je.st
news
Tag: conjugate
01.03.14 -- Five Potential Cancer Targets For Antibody Drug Conjugate Therapy Discovered
2013-12-31 00:29:39| drugdiscoveryonline News Articles
01/03/14Drug Discovery Online Newsletter
Tags: potential
drug
cancer
therapy
Compugen Discloses Discovery Of Five Potential Cancer Targets For Antibody Drug Conjugate Therapy
2013-12-30 05:40:02| drugdiscoveryonline News Articles
Compugen Ltd. recently announced the predictive discovery and selection of five candidate targets for antibody-drug conjugate (ADC) cancer therapy
Tags: potential
drug
cancer
therapy
Seattle Genetics Enters Into New Antibody-Drug Conjugate Collaboration With Bayer
2013-06-25 09:00:00| drugdiscoveryonline News Articles
Seattle Genetics, Inc. recently announced that it has entered into a new antibody-drug conjugate (ADC) collaboration with Bayer HealthCare (Bayer)
Tags: with
collaboration
seattle
enters
Compugen Discloses Focused Target Discovery Program For Antibody-Drug Conjugate Cancer Therapy
2013-04-02 09:55:00| drugdiscoveryonline News Articles
Compugen Ltd. disclosed recently the initiation of its second focused discovery program, aimed at identification of novel targets for antibody-drug conjugate (ADC) cancer therapy focusing on clinical situations with poor survival rates and/or recurrent cancers
Tags: program
target
cancer
focused
APO-T And LinXis Announce Antibody Drug Conjugate Option To In-License Agreement
2013-03-22 09:08:00| drugdiscoveryonline News Articles
APO-T B.V. and LinXis B.V., both privately owned oncology companies, announced recently that LinXis has granted APO-T an exclusive worldwide license for the development and commercialization of fully-human antibody-drug-conjugates using APO-T’s MAGE-HLA targeted antibodies and LinXis’ unique LX linker technology
Tags: agreement
option
drug
announce
Sites : [1] [2]